Cabrera-Mulero, A.; Crujeiras, A.B.; Izquierdo, A.G.; Torres, E.; Ayers, D.; Casanueva, F.F.; Tinahones, F.J.; Morcillo, S.; Macias-Gonzalez, M.
Novel SFRP2 DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI. J. Clin. Med. 2019, 8, 1041.
https://doi.org/10.3390/jcm8071041
AMA Style
Cabrera-Mulero A, Crujeiras AB, Izquierdo AG, Torres E, Ayers D, Casanueva FF, Tinahones FJ, Morcillo S, Macias-Gonzalez M.
Novel SFRP2 DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI. Journal of Clinical Medicine. 2019; 8(7):1041.
https://doi.org/10.3390/jcm8071041
Chicago/Turabian Style
Cabrera-Mulero, Amanda, Ana B. Crujeiras, Andrea G. Izquierdo, Esperanza Torres, Duncan Ayers, Felipe F. Casanueva, Francisco J. Tinahones, Sonsoles Morcillo, and Manuel Macias-Gonzalez.
2019. "Novel SFRP2 DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI" Journal of Clinical Medicine 8, no. 7: 1041.
https://doi.org/10.3390/jcm8071041
APA Style
Cabrera-Mulero, A., Crujeiras, A. B., Izquierdo, A. G., Torres, E., Ayers, D., Casanueva, F. F., Tinahones, F. J., Morcillo, S., & Macias-Gonzalez, M.
(2019). Novel SFRP2 DNA Methylation Profile Following Neoadjuvant Therapy in Colorectal Cancer Patients with Different Grades of BMI. Journal of Clinical Medicine, 8(7), 1041.
https://doi.org/10.3390/jcm8071041
